SAN FRANCISCO & SEATTLE, January 08, 2025--Transcarent, the One Place for Health and Care, and Accolade (NASDAQ:ACCD), a leader in health advocacy, expert medical opinions, and primary care ...

Transcarent, the One Place for Health and Care, and Accolade (ACCD) announced that they have entered into a definitive agreement under which Transcarent will acquire Accolade for $7.03 per share ...

Debt Management: Accolade's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.55. The Significance of Analyst Ratings Explained ...

Accolade reported $106.4 million in revenue for its fiscal quarter ended Aug. 31, up 10% year-over-year, and a net loss of $23.9 million, down from $32.8 million in the year-ago period.

Transcarent and Accolade (ACCD) announced that they have entered into a definitive agreement under which Transcarent will acquire Accolade for $7.03 per share in cash, which represents a total ...